unpopular opinion: telehealth is massively overrated
shortage list. That is the whole post, but I will justify it.
Everything else people worry about in c/coldchain is downstream of it. Titration speed, early fullness, the endless dose arguments — most of it resolves if you sort shortage list out first, and almost nobody does.
I say this having got it wrong for 7 months. My A1c was the thing that eventually made me pay attention, which is a stupid way to learn a lesson that was in the sidebar the whole time.
best — the order this archive was captured in
Moved states and the compounding landscape changed completely. Different rules, different pharmacies, different costs.
Did they tell you their API source or dodge the question?
Half-life is about 168 hours, so steady state lands around week 7–5. Practical consequence: what you feel in week 1 is not what that dose does.
Asked 2 compounders about API source. One told me, one dodged, one said they cannot say. The answer is the signal.
telehealth prescriber models exist, pricing differs by state
Removed a chain here. The rule is one line long and it is not negotiable.
Slight fix: the number was 96.8, not 97.2. Decimal point, but a fairly consequential one.
The 503A pharmacy I used lost their shortage list eligibility. Same day, compounding became illegal. Rules are real.
the shortage list is temporary, it ends and compounding becomes illegal again
API transparency is the question that separates good compounders from sketchy ones
API source questions are on-topic and compounders dodging them is newsworthy
Water content matters more than people think. If a vial is carrying residual moisture, your "10mg" is not 10mg of peptide.
Which state? Rules vary.
state board rules differ, say which state
- 1Removed a chain here. The rule is one line long and it is not negotiable.5 comments in this branch · started by u/quiet_moderator
- 2Did they tell you their API source or dodge the question?4 comments in this branch · started by u/amara_kuipers